Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-Human DCBLD2CLCP1 Antibody (FA19-1)

Catalog #:   DHN05401 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DHN05401

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG

Target

Discoidin, CUB and LCCL domain-containing protein 2, ESDN, DCBLD2, CLCP1, CUB, LCCL and coagulation factor VVIII-homology domains protein 1, Endothelial and smooth muscle cell-derived neuropilin-like protein

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q96PD2

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

FA19-1, FA 19-1

Clone ID

FA19-1

Data Image
References

A novel therapeutic strategy for osteosarcoma using anti-GD2 ADC and EZH2 inhibitor., PMID:40533837

Association of antibody and T cell receptor repertoires in Trypanosoma cruzi infected rhesus macaques and host response to infection., PMID:40533759

Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment., PMID:40533745

Kidney transplant arteriopathy revisited., PMID:40533723

Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer - real-world data from a multicenter German patient population., PMID:40533571

R9AP is a common receptor for EBV infection in epithelial cells and B cells., PMID:40533557

Blocking the functional domain of cancer cell surface TIP1 upregulates Midkine via the β-catenin/Wnt signaling pathway., PMID:40533520

Optimised nanobody-based quenchbodies for enhanced protein detection., PMID:40533519

Somatostatin receptor 2 targeting peptide modifications for peptide-drug conjugate treatment of small cell lung cancer., PMID:40533489

A three dimensional immunolabeling method with peroxidase-fused nanobodies and fluorochromized tyramide-glucose oxidase signal amplification., PMID:40533487

Self-assembling TLR2 agonists promote mucosal immune responses without pulmonary immunopathologic injuries in mice., PMID:40533467

Level of antibody to hepatitis B surface antigen declined below 10 mIU/ml is still protective., PMID:40533440

Characterization of ex vivo expanded natural killer cells for cancer immunotherapy., PMID:40533418

LpX and LpZ associated hypercholesterolemia in a patient with primary sclerosing cholangitis - A case report., PMID:40533384

Exploring the depths of hypogammaglobulinemia in lymphoid malignancies: Pathophysiology, clinical implications, management options, and future directions., PMID:40533299

Validation of Risk Prediction System for Denosumab-Induced Hypocalcemia with an External Clinical Dataset., PMID:40533172

Transverse myelitis following guselkumab treatment for severe plaque psoriasis., PMID:40533109

An Electrochemiluminescence Biosensor for the Screening of Environmental Estrogens Using a Peptide Probe Targeting the Activated Estrogen Receptor., PMID:40533042

Development of a novel system for the expression and production of recombinant monoclonal antibody, tocilizumab, using Pichia pastoris., PMID:40533031

Effects of Ganoderma spent substrate containing with polysaccharides and triterpenoids on the growth performance, antioxidant capacity and immunity level of chickens., PMID:40532998

The role and mechanism of the NLRP3-IL-1β/IL-18 signaling axis in the progression of sepsis under an aging phenotype., PMID:40532971

Efficient gene delivery to immune cells via a recombinant multifunctional chimeric peptide nanocarrier: Implications in immunotherapy., PMID:40532900

Identifying pathogenic contributors of radiodermatitis ameliorated by Smad7-based targeting in canine and mouse models., PMID:40532891

Immunization of rabbits with nanovenom composed of Dendroaspis polylepis venom and silica nanoparticles: a first in vivo approach., PMID:40532884

Conserved domains of flagellin as adjuvants for an inactivated vaccine against porcine epidemic diarrhea virus., PMID:40532846

Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice., PMID:40532840

[Not Available]., PMID:40532789

Oral Adjuvanted Vibrio Vaccine Enhances Antibody Production and Lysozyme Activity in the Serum and Mucus of Marine-cultured Red Hybrid Tilapia (Oreochromis sp.) Against V. harveyi and V. alginolyticus., PMID:40532752

A conserved immune dysregulation signature is associated with infection severity, risk factors prior to infection, and treatment response., PMID:40532705

Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer., PMID:40532664

Amplifying tumor recognition and drug susceptibility by multivalent ApDC assembly to combat with tumor cell heterogeneity., PMID:40532654

Targeting prostate cancer with site-specific antibody-drug conjugates enabled by tandemly fused ADP-ribosyl cyclases., PMID:40532576

Immunologic responses to an extracellular vesicle-based vaccine expressing the full suite of SARS-CoV-2 structural proteins., PMID:40532478

Outcomes with trastuzumab deruxtecan by biomarker status, line of treatment and prior receipt of sacituzumab govitecan in a large real-world database of patients with metastatic breast cancer., PMID:40532362

A Rare Case of Pembrolizumab Induced Pericardial Tamponade in a 77-Year-Old., PMID:40532296

Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer., PMID:40532152

Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study., PMID:40532125

Developing a Two-Dimensional Size-Exclusion Liquid Chromatography Platform for Isolating the High-Quality Extracellular Vesicles to Predict and Evaluate Metabolic Improvement Outcomes of Sleeve Gastrectomy., PMID:40532084

Virus-Like Particle-Based Multiserotype Quartet Vaccine of Dengue Envelope Protein Domain III Elicited Potent Anti-Dengue Responses., PMID:40532066

Predictive factors of radioiodine ablation success: Results from a MEDIRAD prospective clinical study for thyroid cancer., PMID:40532046

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment., PMID:40531973

OX40-heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice., PMID:40531970

Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion., PMID:40531969

Microglial pruning of glycinergic synapses disinhibits spinal PKCγ interneurons to drive pain hypersensitivity in mice., PMID:40531965

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data., PMID:40531962

Untreated HIV-1 infection and low CD4+ T cell counts and their effect on endemic human coronavirus (re)infection., PMID:40531922

[Application of quantitative absorption-elusion reaction for determining the group specificity of blood traces on material evidence]., PMID:40531793

Remdesivir Treatment Outcomes of Subacute Sclerosing Panencephalitis Presenting with Macular Necrotizing Retinitis: A Case Report., PMID:40531784

Mucocutaneous disease: a child with extrapulmonary manifestation of mycoplasma infection., PMID:40531783

Level of agreement between two asthma control questionnaires in children and adolescents., PMID:40531732

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-Human DCBLD2CLCP1 Antibody (FA19-1) [DHN05401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only